World's Best Scientists 2026 revealed!
Journal of Nanobiotechnology
H-index 67

Journal of Nanobiotechnology

1477-3155

Published by: Springer

https://jnanobiotechnology.biomedcentral.com

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Materials Science 128 281 359 49

Additional Metrics

Number of Best Scientists*: 683
Documents by Best Scientists*: 752
Top 100 Ranked Scientists*: 19
SCIMAGO H-index: 125
SCIMAGO SJR: 2.282
Impact Factor: 12.6

Overview

Top Research Topics at Journal of Nanobiotechnology?

Nanotechnology, In vivo, Biophysics, Cancer research and Nanoparticle are the subjects of interest in Journal of Nanobiotechnology. Nanotechnology studies presented include Colloidal gold, Nanomaterials, Nanomedicine, Biomolecule and Magnetic nanoparticles. While it focused on In vivo, it was also able to explore topics like In vitro, Photothermal therapy, Drug delivery, Pharmacology and Biomedical engineering.

The Drug delivery study tackling the subject of Nanocarriers is the focus of it. Journal of Nanobiotechnology addresses concerns in Biophysics which are intertwined with other disciplines, such as Biocompatibility, Fluorescence and Cytotoxicity. The studies on Cancer research discussed can also contribute to research in the domains of Cancer cell, Cancer, Apoptosis and Molecular medicine.

  • Nanotechnology (23.63%)
  • In vivo (20.97%)
  • Biophysics (19.76%)

What are the most cited papers published in the journal?

  • APPLICATIONS OF NANOPARTICLES IN BIOLOGY AND MEDICINE (1603 citations)
  • Interaction of silver nanoparticles with HIV-1 (1197 citations)
  • Nano based drug delivery systems: recent developments and future prospects (1177 citations)

Research areas of the most cited articles at Journal of Nanobiotechnology:

The most cited articles facilitate discussions on Nanotechnology, Nanoparticle, Biophysics, Drug delivery and Silver nanoparticle. In addition to Nanotechnology research, the published articles aim to explore topics under Chemical engineering and Particle size. The journal publications address concerns in Drug delivery which are intertwined with other disciplines, such as Biocompatibility, Drug, Nanomedicine and In vivo.

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Nanobiotechnology (based on the number of publications) are:

  • Kenji Yasuda (12 papers) absent at the last edition,
  • Shlomo Margel (10 papers) absent at the last edition,
  • Wolfgang J. Parak (8 papers) absent at the last edition,
  • Mikhail Soloviev (7 papers) absent at the last edition,
  • Beatriz Pelaz (7 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Nanobiotechnology (based on the number of publications) are:

  • Shanghai Jiao Tong University (60 papers) published 31 papers at the last edition, 17 more than at the previous edition,
  • Chinese Academy of Sciences (30 papers) published 18 papers at the last edition, 14 more than at the previous edition,
  • Zhejiang University (25 papers) published 18 papers at the last edition, 16 more than at the previous edition,
  • Fudan University (25 papers) published 12 papers at the last edition, 5 more than at the previous edition,
  • Nanjing Medical University (21 papers) published 6 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.86% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.91% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.56% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.87% of all publications and 37.66% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Correction to: Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer

    Unknown

    (2022)
    311 Citations
  • Synthesis of graphene quantum dots and their applications in drug delivery

    Changhong Zhao;Changhong Zhao;Xuebin Song;Ya Liu;Yifeng Fu

    (2020)
    293 Citations
  • PLA-lignin nanofibers as antioxidant biomaterials for cartilage regeneration and osteoarthritis treatment

    Unknown

    (2022)
    146 Citations
  • Biodegradable polymer nanocomposites for ligament/tendon tissue engineering

    Magda Silva;Fernando N. Ferreira;Natália M. Alves;Maria C. Paiva

    (2020)
    143 Citations
  • Porous gold nanoparticles for attenuating infectivity of influenza A virus

    Jinyoung Kim;Minjoo Yeom;Taeksu Lee;Hyun Ouk Kim

    (2020)
    138 Citations
  • CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants

    (2023)
    135 Citations
  • Simvastatin induced ferroptosis for triple-negative breast cancer therapy

    Xianxian Yao;Ruihong Xie;Yongbin Cao;Jing Tang

    (2021)
    131 Citations
  • Nanomedicine-enabled chemotherapy-based synergetic cancer treatments

    (2022)
    118 Citations
  • The advances in nanomedicine for bone and cartilage repair

    (2022)
    110 Citations
  • Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical

    (2022)
    108 Citations

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to a variety of career paths in healthcare and science. For those considering a transition into nursing, exploring easy nurse practitioner programs to get into can be a strategic step to advance clinical skills without overwhelming admission barriers.

Alternatively, if you're interested in the administrative side of healthcare, understanding the dynamics of medical coding is important. There are ongoing discussions about whether is medical coding a dying career, so researching industry trends can help you make informed career decisions.

For current nurses aiming to enhance their qualifications, online options like rn to bsn online programs provide flexible learning without clinical requirements, allowing professionals to improve credentials while continuing to work.

Those seeking advanced practice roles might consider accelerated paths such as the shortest msn to dnp program, which offers a time-efficient route to doctoral-level nursing practice, combining expertise in chemistry and healthcare to impact patient outcomes.

Best Scientists Contributing to This Journal